CME Group (CME) Stock Price, News & Analysis

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 2 sell ratings, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CME shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares.
View CME analyst ratings or view top-rated stocks.

9 analysts have issued 12-month price targets for CME Group's stock. Their CME share price targets range from $180.00 to $240.00. On average, they predict the company's stock price to reach $213.89 in the next year. This suggests a possible upside of 4.8% from the stock's current price.
View analysts price targets for CME or view top-rated stocks among Wall Street analysts.

CME Group's stock was trading at $210.60 on January 1st, 2024. Since then, CME shares have decreased by 3.1% and is now trading at $204.00.
View the best growth stocks for 2024 here.

CME Group saw a drop in short interest during the month of January. As of January 15th, there was short interest totaling 3,790,000 shares, a drop of 6.4% from the December 31st total of 4,050,000 shares. Based on an average daily trading volume, of 1,800,000 shares, the short-interest ratio is currently 2.1 days. Currently, 1.1% of the company's shares are short sold.
View CME Group's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 14th 2024.
View our CME earnings forecast.

CME Group will be holding an earnings conference call on Wednesday, February 14th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

CME Group Inc. (NASDAQ:CME) issued its quarterly earnings data on Wednesday, July, 26th. The financial services provider reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.20 by $0.10. The financial services provider earned $1.36 billion during the quarter, compared to analysts' expectations of $1.34 billion. CME Group had a trailing twelve-month return on equity of 11.70% and a net margin of 57.03%. The company's revenue was up 9.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.97 earnings per share.
Read the conference call transcript.

CME Group announced a quarterly dividend on Thursday, February 8th. Stockholders of record on Friday, March 8th will be given a dividend of $1.15 per share on Tuesday, March 26th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.25%. This is a positive change from the stock's previous quarterly dividend of $1.10.
Read our dividend analysis for CME.

CME Group (NASDAQ:CME) pays an annual dividend of $4.40 per share and currently has a dividend yield of 2.17%. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 52.51%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME will have a dividend payout ratio of 46.46% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CME.

ETFs with the largest weight of CME Group (NASDAQ:CME) stock in their portfolio include iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI), Horizon Kinetics Blockchain Development ETF (BCDF), Tema Monopolies and Oligopolies ETF (TOLL), SmartETFs Dividend Builder ETF (DIVS), TrueShares Low Volatility Equity Income ETF (DIVZ), Capital Link Global Fintech Leaders ETF (KOIN), VanEck Morningstar ESG Moat ETF (MOTE) and Amplify Transformational Data Sharing ETF (BLOK).

294 employees have rated CME Group Chief Executive Officer Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among the company's employees. 80.0% of employees surveyed would recommend working at CME Group to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), Walt Disney (DIS), Visa (V), Netflix (NFLX), Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).

CME Group's stock is owned by many different retail and institutional investors. Top institutional investors include GUARDCAP ASSET MANAGEMENT Ltd (1.10%), Fiera Capital Corp (0.96%), Raymond James & Associates (0.78%), Massachusetts Financial Services Co. MA (0.71%), California Public Employees Retirement System (0.70%) and Sarasin & Partners LLP (0.63%). Insiders that own company stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Martin J Gepsman, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy Francis Mccourt, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends.

Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.